CCB International (Holdings) Limited - Net Worth and Insider Trading

CCB International (Holdings) Limited Net Worth

The estimated net worth of CCB International (Holdings) Limited is at least $275 Million dollars as of 2025-06-07. CCB International (Holdings) Limited is the 2201 Interest of corporation controlled by you of Beijing Luzhu Biotechnology Co Ltd and owns about 11,664,075 shares of Beijing Luzhu Biotechnology Co Ltd (HKSE:02480) stock worth over $275 Million. Details can be seen in CCB International (Holdings) Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that CCB International (Holdings) Limited has not made any transactions after 2023-05-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of CCB International (Holdings) Limited

CCB International (Holdings) Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, CCB International (Holdings) Limited owns 1 companies in total, including Beijing Luzhu Biotechnology Co Ltd (HKSE:02480) .

Click here to see the complete history of CCB International (Holdings) Limited’s form 4 insider trades.

Insider Ownership Summary of CCB International (Holdings) Limited

Ticker	Company	Transaction Date	Type of Owner
HKSE:02480	Beijing Luzhu Biotechnology Co Ltd	2023-05-08	2201 Interest of corporation controlled by you

CCB International (Holdings) Limited Latest Holdings Summary

CCB International (Holdings) Limited currently owns a total of 1 stock. CCB International (Holdings) Limited owns 11,664,075 shares of Beijing Luzhu Biotechnology Co Ltd (HKSE:02480) as of May 8, 2023, with a value of $275 Million.

Latest Holdings of CCB International (Holdings) Limited

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02480	Beijing Luzhu Biotechnology Co Ltd	2023-05-08	11,664,075	23.60	275,272,170

Holding Weightings of CCB International (Holdings) Limited

CCB International (Holdings) Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, CCB International (Holdings) Limited has made a total of 1 transactions in Beijing Luzhu Biotechnology Co Ltd (HKSE:02480) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Beijing Luzhu Biotechnology Co Ltd is the sale of 11,664,075 shares on May 8, 2023, which brought CCB International (Holdings) Limited around $0.

Insider Trading History of CCB International (Holdings) Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

CCB International (Holdings) Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

CCB International (Holdings) Limited Ownership Network

Ownership Network List of CCB International (Holdings) Limited

No Data

Ownership Network Relation of CCB International (Holdings) Limited

CCB International (Holdings) Limited Owned Company Details

What does Beijing Luzhu Biotechnology Co Ltd do?

Who are the key executives at Beijing Luzhu Biotechnology Co Ltd?

CCB International (Holdings) Limited is the 2201 Interest of corporation controlled by you of Beijing Luzhu Biotechnology Co Ltd. Other key executives at Beijing Luzhu Biotechnology Co Ltd include 2101 Beneficial owner Kong Jian , 2202 Interest of your spouse Zhang Yanping , and 2201 Interest of corporation controlled by you Ma Jianan .

Beijing Luzhu Biotechnology Co Ltd (HKSE:02480) Insider Trades Summary

Over the past 18 months, CCB International (Holdings) Limited made no insider transaction in Beijing Luzhu Biotechnology Co Ltd (HKSE:02480). Other recent insider transactions involving Beijing Luzhu Biotechnology Co Ltd (HKSE:02480) include a net sale of 0 shares made by Kong Jian , a net sale of 0 shares made by Zhang Yanping , and a net sale of 0 shares made by China Construction Bank Corporation .

In summary, during the past 3 months, insiders sold 0 shares of Beijing Luzhu Biotechnology Co Ltd (HKSE:02480) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Beijing Luzhu Biotechnology Co Ltd (HKSE:02480) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Beijing Luzhu Biotechnology Co Ltd (HKSE:02480)'s detailed insider trading history can be found in Insider Trading Tracker table.

Beijing Luzhu Biotechnology Co Ltd Insider Transactions

No Available Data

CCB International (Holdings) Limited Mailing Address

Above is the net worth, insider trading, and ownership report for CCB International (Holdings) Limited. Currently GuruFocus does not have mailing address information for CCB International (Holdings) Limited.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.